Eagles fear plantar fascia tear could sideline Will Shipley for multiple games

The Philadelphia Eagles may be facing a significant running-back shortage as the 2026 season enters its stretch run. According to a report attributed to NFL insider Adam Schefter, Eagles running back Will Shipley suffered a partial tear of his plantar fascia and could miss multiple games.

Plantar fascia injuries are particularly difficult for running backs because the plantar fascia plays a central role in push-off and change-of-direction. Even when athletes return, teams often manage reps and rushing attempts carefully early on to limit flare-ups. In other words, a “multiple-game” absence does not just remove a player from the lineup, it can also force a reconfiguration of how the offense generates chunk plays on the ground.

Shipley’s status matters because the report frames him as part of Philadelphia’s top tier of options at the position. If Philadelphia indeed has to account for the loss of more than one of its primary rushers over the same window, the team’s approach could shift quickly, with greater reliance on remaining backs and a higher frequency of plays that maximize passing-game protection and neutralize defensive pressure.

For offensive coordinators, the loss of a back who can run, pass protect, and participate in short-area routes changes more than just the rushing ledger. Teams often need to adjust pass protections and screen concepts, because the backup roles are not identical. In Philadelphia’s case, any drop in run-game reliability also affects play-action timing, because opponents can start defending the run more aggressively if the offense cannot establish consistent interior traction.

The injury report also raises questions about workload distribution within the Eagles’ backfield. If Shipley is held out for multiple weeks, Philadelphia may lean on its next man up while determining how to split touches so the remaining backs stay fresh and productive. That can include more committee-style rotations, with potential knock-on effects for special teams participation and in-game substitutions.

The Eagles, like every NFL club, will prioritize clarity on the timeline as doctors and team staff monitor pain and functional recovery. Until there is a direct confirmation from the team’s official injury designation process, the “could miss multiple games” framing should be treated as a cautious expectation rather than a precise forecast for each upcoming week.

What to watch next is whether Philadelphia releases further medical details or official practice participation updates, and how quickly the backfield rotation stabilizes. The early signs will likely show up in rushing attempts distribution, red-zone usage of the remaining backs, and whether Philadelphia can maintain its balance between the run and the pass without Shipley’s specific skill set.